Wolfgang Pieken

MWG-Biotech AG engaged in development and research of synthetic DNA. The company was founded in 1990 and was headquartered in Ebersberg, Germany.

Ipsat Therapies Oy develops and manufactures antibiotics & drugs. Its products include penicillins, cephalosporins and carbapenems. The firm develops products for the prevention of antibiotic resistance, antibiotic-associated diarrhea and hospital associated infections. The company was founded in 2000 and is headquartered in Helsinki, Finland.

multimmune GmbH develops therapeutic approaches for the treatment of cancers and infectious disease. It engages in the discovery and development of novel products for the treatment of cancer and infectious diseases through its manipulation of the immune system. The company was founded by Claus Botzler and Gabriele Multhoff in 1999 and is headquartered in Munich, Germany.

BioSilta Ltd. provides cell culture technology for laboratory researchers. It develops different uses of enzyme and biocatalytic activity to advance cell culture technology across a range of product formats and bacteria. The company was founded by Peter Neubauer in 2007 and is headquartered in Oulu, Finland.

Lx Therapies Oy provides drug discovery solutions for cancer treatment. It focused on developing gene mediated therapies for the prevention and treatment of diseases of lymphatic vasculature. Its therapies are used for the treatment of breast cancer related lymphoedema. The company was founded in 2008 and is headquartered in Helsinki, Finland.

miacom diagnostics GmbH develops and distributes rapid molecular diagnostic tests for the identification of pathogens directly from patient material. Its products include hemoFISH Gram, hemoFISH Masterpanel, hemoFISH S.aureus and CNS Screen, respiFISH HAP Gram Panel, respiFISH HAP Masterpanel, FISH Probes, Combined hotplate and hybridization chamber, 8-channel pipette, and fluorescence microscopes. The company was founded by Ian Thrippleton and Walter Freiherr von Stein in 2009 and is headquartered in Düsseldorf, Germany.

Ventac Partners GMBH offers life sciences consultancy services. Its consulting services include due diligence, education and training, market analysis, product development and valuation. The company was founded by Mikael Oerum in 2002 and is headquartered in Munich, Germany.

Priaxon AG operates as a drug discovery company for small molecule therapeutics. The firm develops a platform PriaXplore that consists of several chemo informatics methods and concepts especially designed for the application in the field of identifying new potential inhibitors of protein protein interactions (PPI). The company was founded by Christoph Burdack in 2008 and is headquartered in Munich, Germany.